Wan-Teck Lim

24PUBLICATIONS
150CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyPredictive and prognostic markersCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Aug 11, 2026
Early EGFR Inhibition Triggers Actionable Tumor and Microenvironmental Remodeling in Lung Cancer.

|Apr 10, 2026
Distribution of Immune Cells in Tumor Microenvironment Correlates With Checkpoint Inhibitor Response in Nasopharyngeal Carcinoma: A Multiregional Study.

Bhumsuk Keam, Darren Wan-Teck Lim, Hsiang-Fong Kao

|Apr 07, 2026
A First-in-Human Phase I Clinical Trial Evaluating Clinical Activity and Proof of Mechanism of Tobemstomig, a PD-1-LAG-3 Bispecific Antibody, in Patients with CPI-Experienced Melanoma.

Elena Garralda, Christoph Markert, Victor Moreno

|Feb 04, 2026
Repotrectinib in NTRK fusion-positive advanced solid tumors: a phase 1/2 trial.

Benjamin Besse, Jessica J Lin, Lyudmila Bazhenova

|Aug 28, 2025
Novel Therapeutic Strategies for Squamous Cell Carcinoma of the Head and Neck: Beyond EGFR and Checkpoint Blockade.

Rachel Hui Zhen Sim, Pei Jye Voon, Seng Wee Cheo

|Mar 28, 2025
Development of a miRNA-Based Model for Lung Cancer Detection.

Kai Chin Poh, Toh Ming Ren, Goh Liuh Ling

Pageof 4

Frequent Collaborators

5 joint publications

Aaron C Tan

4 joint publications

Narayanan Gopalakrishna Iyer

4 joint publications

Daniel Shao-Weng Tan

3 joint publications

Angela Takano